The Akt, Ras and STAT5 signaling pathways have each been linked to transformation of hematopoietic cells by BCR/ABL. However the relative contributions of these signaling pathways to BCR/ABL mediated cytokineindependent survival, proliferation and resistance to DNA damage-induced apoptosis have not been systematically de®ned. Here we report that activation of either Akt, Ras or STAT5 confers cytokine-independent survival to IL-3 dependent BaF3 cells. Ras or STAT5, but not Akt, also drives cytokine-independent proliferation and imparts sustained resistance to DNA damageinduced apoptosis. We also show that dominant negative (DN) inhibition of STAT5, but not Ras or Akt, signi®cantly reduces resistance to DNA damage-induced apoptosis in BCR/ABL transformed BaF3 cells. Whereas inhibition of STAT5 or Ras alone does not compromise cytokine-independent proliferation of BaF3-BCR/ABL cells, simultaneous blockade of both STAT5 and Ras reduces proliferation and maximally sensitizes BaF3-BCR/ABL cells to DNA damage induced by girradiation, suggesting a cooperative role for these two signaling pathways in BCR/ABL transformation. The anti-apoptotic properties of BCR/ABL can be partly explained by an increase in the expression of Pim-1 and Bcl-XL, as ectopic expression of these STAT5 target genes imparts both cytokine-independent survival and partial g-radiation resistance. These data illustrate both cooperative and redundant eects of STAT5 and Ras signaling in BCR/ABL transformed cells, with STAT5 playing a dominant role in resistance to DNA damageinduced apoptosis. Oncogene (2001) 20, 5826 ± 5835.
Introduction
Chronic myelogenous leukemia (CML) is a malignancy of the hematopoietic stem cell characterized in the initial chronic phase by an expansion of myeloid progenitors that maintain normal dierentiation. This relatively indolent stage inevitably evolves to a phase known as blast crisis, which resembles acute leukemia and is ultimately fatal. The cytogenetic hallmark of CML, the Philadelphia chromosome (Ph+), is produced by a reciprocal translocation between chromosomes 9 and 22. The resulting chimeric fusion protein, BCR/ABL (Ben-Neriah et al., 1986) , is an activated cytoplasmic tyrosine kinase that impinges upon the normally tight cytokine regulation of the hematopoietic system and is thus central to the development of CML. The causative role of BCR/ABL in CML has been demonstrated in animal models (Daley et al., 1990) .
When expressed in cytokine-dependent hematopoietic cells, BCR/ABL provides signals for growth factor independent survival, proliferation, and resistance to apoptosis induced by DNA damage (Bedi et al., 1995; Cambier et al., 1998; Daley and Baltimore, 1988; Dubrez et al., 1998) . These eects of BCR/ABL have close correlates in primary leukemia cells from CML patients (Jiang et al., 1999) . Though there is con¯icting evidence as to whether primary Ph+ hematopoietic cells are resistant to apoptosis (Amos et al., 1995; Bedi et al., 1994) , treatment of CML patients with the speci®c kinase blocker STI 571 induces apoptosis of hematopoietic cells and normalization of cell counts (Horita et al., 2000) . Inappropriate inhibition of apoptosis in the face of DNA damage may explain the inherent genomic instability of Ph+ clones and the accumulation of secondary mutations associated with evolution from chronic phase to blast crisis. These observations suggest that the ability of BCR/ABL to substitute for cytokine signaling and inhibit apoptosis in cultured hematopoietic cell lines is relevant to our understanding of disease pathogenesis and treatment.
BCR/ABL function is dependent on its activated tyrosine kinase (Lugo et al., 1990) as well as multiple structural domains that couple the fusion protein to numerous eector pathways (Goga et al., 1995) . BCR/ ABL mediated transformation correlates with the activation of several cytokine signaling intermediates, including Ras (Cortez et al., 1996; Mandanas et al., 1993) , phosphatidylinositol-3 (PI3) kinase (Skorski et al., 1997) , Akt (Skorski et al., 1997) , Raf-1 (Skorski et al., 1995) , NF-kB (Reuther et al., 1998) , JAK2 (Wilson-Rawls et al., 1996) and STAT5 (Ilaria and Van Etten, 1996) .
Several lines of evidence suggest that activation of Akt, Ras and STAT5 represent distinct BCR/ABL signaling mechanisms that play major roles in BCR/ ABL mediated transformation. Akt is a serine/ threonine kinase that inhibits the pro-apoptotic molecule BAD (Datta et al., 1997) , thereby increasing the Bcl-XL/BAD ratio and promoting survival. Akt is an eector molecule of PI3 kinase, which is activated directly by BCR/ABL (Skorski et al., 1997) . BCR/ ABL activates the Ras proto-oncogene in part through interaction with the adapter proteins Grb2 and Shc (Goga et al., 1995; Puil et al., 1994) . Ras is a critical component of growth factor signaling (reviewed in Rebollo and Martinez, 1999) and may be involved in the development of a number of hematological malignancies (Janssen et al., 1987) . STAT5 is encoded by two similar genes, STAT5a and STAT5b, which belong to a family of transcription factors that play major roles in cytokine signaling (Darnell, 1997; Ihle et al., 1998) . The exact mechanism by which BCR/ABL activates STAT5 remains unclear, though it appears to be independent of JAK2 (Ilaria and Van Etten, 1996) and involves both the SH2 and SH3 domains of BCR/ABL (Nieborowska-Skorska et al., 1999) .
In addition to their roles in providing antiapoptotic and/or proliferative signals in dierent systems, Akt (Skorski et al., 1997) , Ras (Pendergast et al., 1993) and STAT5 (Nieborowska-Skorska et al., 1999) have each been linked to BCR/ABL mediated leukemia. However, the cooperative or independent contribution of these pathways to dierent aspects of BCR/ABL transformation have never been systematically or quantitatively compared, and the downstream target molecules have not been fully explored. Therefore in the present study we have analysed the contributions of Akt, Ras and STAT5 to BCR/ABL mediated cytokine-independent survival, proliferation, and resistance to DNA damage induced apoptosis. Our data provide a relative comparison of the speci®c and redundant roles of these three major BCR/ABL eector molecules and undermines the supposition that any one speci®c signaling pathway is critical for the BCR/ABL transformed phenotype.
Results

Activity of mutant forms of Akt, Ras and STAT5
BCR/ABL activates a number of signal transduction pathways that are also activated by IL-3, including Akt, Ras and STAT5. As a general strategy to determine which of these pathways might account for dierent aspects of BCR/ABL transformation, BaF3 cells were transduced with a bicistronic retrovirus encoding GFP together with activated mutants of STAT5a, Ras or Akt. Conversely, BaF3 cells expressing BCR/ABL (BaF3-BCR/ABL) were transduced with retroviruses encoding dominant negative forms of STAT5a/b, Ras or Akt. GFP positive cells were isolated by FACS and assayed for speci®c phenotypes associated with BCR/ABL transformation.
We used several assays to con®rm that the activated and dominant negative forms of STAT5, Ras and Akt were functioning in an appropriate manner. Using electromobility shift assays (EMSA), we veri®ed that both dominant negative (DN) STAT5b and constitutively active (CA) STAT5a mutants were expressed at high levels in BaF3-BCR/ABL and parental BaF3 cells, respectively (Figure 1a ). RT ± PCR analysis showed that the relative levels of the STAT5 target gene CIS were increased in BaF3 cells by IL-3, CA-STAT5a, or BCR/ABL, and inhibited by DN-STAT5b (Figure 1b) . Likewise, the relative levels of the Ras target gene cFos were induced by activated (61L) Ras or BCR/ ABL, and decreased in BaF3-BCR/ABL expressing DN-Ras (Figure 1c ). To ensure that RT ± PCR analysis accurately re¯ected relative levels of gene expression, reactions were analysed within linear range of ampli®cation, which was determined by analysis of successive PCR cycles and template dilutions (not shown). EMSA analysis of AP-1 DNA binding ( Figure  1d ) showed induction by IL-3, Ras 61L, or BCR/ABL, and inhibition by DN-Ras. We have previously shown that expression of DN-Ras in BCR/ABL transformed BaF3 cells signi®cantly reduces levels of GTP bound (active) Ras and decreases colony formation in soft agar (Peters et al., 2001) . In vitro kinase assays were used to monitor activation or inhibition of Akt. Akt kinase activity increased in response to treatment with IL-3 and expression of activated (myr) Akt and modestly elevated by BCR/ABL (Figure 1e ). Expression of DN-Akt mutant BaF3-BCR/ABL cells reduced Akt kinase activity by about 75% (Figure 1e ), comparable to cytokine starved BaF3 cells.
Akt, Ras and STAT5 protect BaF3 cells from IL-3 deprivation but only Ras and STAT5 confer IL-3 independent proliferation
Transduction of BaF3 cells with retrovirus encoding activated mutants of either Akt, Ras, or STAT5 signi®cantly increased survival after IL-3 withdrawal compared to cells transduced with vector sequences (Figure 2a ). These data indicate that activation of any one of these pathways is sucient to protect BaF3 cells from apoptosis induced by cytokine deprivation.
We next measured the IL-3 independent proliferation of BaF3 cells expressing the activated mutants of Akt, Ras, or STAT5a. In the absence of IL-3, BaF3 cells transduced with a retrovirus encoding CA-STAT5a proliferated at the same rate as BaF3-BCR/ABL cells (Figure 2b ). BaF3 cells transduced with a retrovirus encoding Ras 61L also proliferated in the absence of cytokine. However, these cells had a doubling time 2 ± 3 times that of BaF3 cells expressing BCR/ABL or CASTAT5a (Figure 2b ). In contrast, BaF3 cells expressing myr-Akt failed to proliferate (Figure 2b ), although these cells remain viable (Figure 2a ). These data indicate that activation of either the Ras or STAT5 pathways is sucient for IL-3 independent survival and proliferation, whereas activation of Akt imparts a signal for cell survival but not proliferation. 
STAT5 and Ras cooperate in BCR/ABL mediated proliferation
Considering that ectopic expression of CA-STAT5a or Ras 61L promote IL-3 independent survival, proliferation and radiation resistance in BaF3 cells, we set out to determine whether inhibition of these pathway would antagonize the eects of BCR/ABL. BaF3-BCR/ABL cells expressing DN-STAT5a (not shown), DN-STAT5b, DN-Ras, or DN-Akt survived and proliferated in the absence of IL-3 similar to BaF3-BCR/ABL cells transduced with empty vector ( Figure  4 ), suggesting that IL-3 independent survival and proliferation is mediated by redundant signaling pathways. The proliferation rate of BaF3-BCR/ABL cells expressing both DN-Ras and DN-STAT5b was decreased to about 50% as compared to parental BaF3-BCR/ABL cells (Figure 4b ). The decrease in viable cell number seen with inhibition of both Ras and STAT5 was not due to a signi®cant increase in apoptosis as measured by Trypan blue dye exclusion Induction of Bcl-XL and Pim-1 gene expression by STAT5 partially explains IL-3 independent survival and resistance to DNA damage-induced apoptosis To de®ne molecular pathways by which BCR/ABL blocks apoptosis, and to relate activation of Akt, Ras, and STAT5 to speci®c target genes, we analysed the expression of several genes that have been linked to proliferation and apoptosis in hematopoietic cells, We found that BCR/ABL increased the expression of both Ras and STAT5 target genes (Figure 6 ). RT ± PCR analysis also showed that transduction of BaF3 cells with activated STAT5 or Ras increased target gene expression to comparable levels as BCR/ABL (Figure 6 ). This observation suggests that the phenotypes associated with BaF3 cells expressing CA-STAT5 or Ras 61L are not due to aberrant overexpression of target genes, but are indeed relevant to BCR/ABL signaling.
We determined whether ectopic expression of any of these target genes alone or in combination could account for BCR/ABL mediated cell survival, proliferation, or g-radiation resistance. Expression of Pim-1 or Bcl-XL in BaF3 cells, even at levels signi®cantly higher than BaF3-BCR/ABL cells (not shown), provided for signi®cant cell survival up to 48 h after IL-3 withdrawal, but failed to maintain cell viability following g-irradiation (Figure 7a,b) . Transduction of cells expressing either Pim-1 or Bcl-XL with a retrovirus encoding c-Myc had no eect on the observed phenotype (not shown). BaF3 cells expressing both Pim-1 and Bcl-XL had signi®cantly greater viability 24 h following g-irradiation than BaF3 cells expressing either Pim-1 or Bcl-XL alone (P50.005, ANOVA), suggesting a cooperative role for these genes (Figure 7b ). However, this cooperative eect was transient as expression of Pim-1 and Bcl-XL together does not protect BaF3 cells signi®cantly better at 72 h following g-irradiation (Figure 7b ), suggesting that additional target molecules are required for complete recovery following DNA damage. Expression of c-Myc in BaF3-Bcl-XL/Pim-1 cells did not aect cell viability following IL-3 withdrawal or irradiation, but did promote modest IL-3 independent proliferation (not shown). BaF3 cells expressing Pim-1, Bcl-XL, and cMyc had a doubling time of approximately 144 h, 10 times that of BaF3 cells expressing CA-STAT5a, suggesting that an increase in c-Myc expression alone cannot account for cytokine-independent proliferation. Discussion BCR/ABL activates a complex network of signal transduction pathways through its deregulated tyrosine kinase and multiple protein ± protein interactions. Several of these pathways, namely Ras (Pendergast et al., 1993), Akt (Skorski et al., 1997) and STAT5 (Nieborowska-Skorska et al., 1999) , have been implicated in BCR/ABL-mediated leukemogenesis. However, the relative contributions of the Ras, STAT5, and Akt signaling molecules have not been systematically associated with known biological consequences of BCR/ABL transformation such as cytokine-independent survival, cytokine-independent proliferation, and resistance to apoptosis induced by genotoxic agents. By introducing dominant active or negative mutants of Akt, Ras, and STAT5 into parental BaF3 and BaF3-BCR/ABL cells, respectively, we set out to determine whether these signaling proteins played essential or redundant roles in the central phenotypes of BCR/ABL transformation. Our data demonstrate that STAT5 signaling plays a dominant role in BCR/ABL-mediated resistance to DNA damage, while both STAT5 and Ras pathways drive cell proliferation. Akt signaling apparently plays a more limited role, as it supports cytokine-independent cell survival but neither cell proliferation nor radiation resistance.
Our data suggest that the signaling pathways we have examined play redundant roles in BCR/ABL transformation of hematopoietic cells, as inhibition of Ras, Akt, or STAT5 alone has no major eect on survival or proliferation in BaF3-BCR/ABL cells. Previous studies have suggested that inhibition of single BCR/ABL eector pathways had signi®cant eects on BCR/ABL mediated survival. A recent study showed that dominant negative inhibition of STAT5 compromised BCR/ABL mediated cell viability (Sillaber et al., 2000) . However only a small percentage of cells appeared to undergo apoptosis in this study, indicating that additional pathways mediate cell survival, as our data support. An additional study using DN-Ras expressed from a glucocorticoid inducible promoter suggested that Ras inhibition was sucient to induce apoptosis in BCR/ABL transformed 32D cells (Cortez et al., 1996) . This apparent contradiction to our data may be explained by additive eects of glucocorticoid stimulation and Ras inhibition, dierences in cell type, or dierent levels of DNRas expression. We have also shown that proliferation of BaF3 cells can be driven by activation of either Ras or STAT5, but not Akt. Moreover, proliferation of BaF3-BCR/ABL cells is abrogated when both Ras and STAT5 are targeted by DN mutants, suggesting that Ras and STAT5 play redundant roles in BCR/ABL mediated proliferation.
Our observations on BCR/ABL signal transduction parallel those made on the erythropoietin (EPO) and IL-3 receptors, where cytokine stimulation leads to activation of multiple downstream mediators of survival and proliferation (Klingmuller et al., 1996) . Indeed, although STAT5 plays a major role in the survival of erythroid progenitors (Socolovsky et al., 1999) , it is not required for EPO induced cell proliferation (Quelle et al., 1996) , suggesting the presence of redundant proliferative signals from the EPO receptor. Likewise, inhibition of either Ras (Terada et al., 1995) , STAT5 (Rosa Santos et al., 2000) , or PI 3-kinase (Rosa Santos et al., 2000) has no eect on IL-3 mediated survival or proliferation of BaF3 cells, but blockade of both STAT5 and PI3-kinase induces apoptosis in BaF3 cells, suggesting cooperation between these two pathways in IL-3 mediated survival (Rosa Santos et al., 2000) .
Although BCR/ABL mediated survival and proliferation are regulated by redundant signaling pathways, STAT5 plays a dominant role in resistance to girradiation induced apoptosis, as well as resistance to cytabarine and hydroxyurea induced apoptosis (Sillaber et al., 2000) . The role of STAT5 in resistance to girradiation is not speci®c to the BaF3 cell line because dominant negative inhibition of STAT5 also sensitizes BCR/ABL transformed 32D cells (not shown). Interestingly, we found that BaF3-BCR/ABL cells expressing both DN-STAT5 and DN-Ras are signi®cantly more sensitive to g-irradiation than cells expressing DN-STAT5 alone. Although STAT5 plays a dominant role in abrogating DNA damage-induced apoptosis, our data suggest that both Ras and STAT5 activation are necessary for maximal protection against DNA damage and emphasize the importance of identifying downstream eectors of both pathways.
To better understand the mechanisms by which STAT5 and Ras may be promoting cytokine-independent survival and resistance to g-irradiation, we analysed the expression level of a number of genes previously identi®ed as having anti-apoptotic properties. We found that STAT5 increased the expression of Pim-1, a serine/threonine kinase shown previously to promote cytokine-independent survival (Lilly and Kraft, 1997) . Both Ras and STAT5 induced the expression of Bcl-XL, a member of the Bcl-2 family of anti-apoptotic proteins. An increase in Pim-1 and Bcl-XL gene expression only partially explains the antiapoptotic properties of BCR/ABL, as ectopic expression of these genes does not completely rescue BaF3 cells from g-irradiation-induced apoptosis. Furthermore, BaF3 cells ectopically expressing Bcl-XL and Pim-1 remain dependent on IL-3 for proliferation, indicating that additional signals are necessary to drive cytokine-independent growth. Our demonstration that Bcl-XL is a STAT5 target gene and may have a role in BCR/ABL mediated survival con®rms previous reports (Amarante-Mendes et al., 1998; Horita et al., 2000; Sanchez-Garcia and Grutz, 1995; Socolovsky et al., 1999) , while the role of Pim-1 in BCR/ABL mediated resistance to apoptosis is a novel ®nding.
Our observation that inhibition of single BCR/ABL eector pathways does not completely abrogate BCR/ ABL mediated transformation has been supported by recent studies using mice in which the genes encoding STAT5a and STAT5b have both been deleted by homologous recombination. Lethally irradiated mice receiving STAT5a/b de®cient bone marrow transduced with a BCR/ABL encoding retrovirus succumb to leukemia (Sexl et al., 2000) , indicating that STAT5 is not required for CML induction by BCR/ABL. In contrast, STAT5 de®cient mice are resistant to leukemia induced by the TEL/JAK2 oncoprotein (Schwaller et al., 2000) . These genetic studies imply that while speci®c inhibition of STAT5 signaling would have little eect on the survival of Ph+ leukemic cells, TEL/JAK2 leukemic cells would be highly sensitive to STAT5 inhibition. Furthermore, based on our observations, we would predict that BCR/ABL positive leukemic cells derived from STAT5a/b de®cient mice would have greater sensitivity to genotoxic agents or inhibition of additional pathways (such as Ras) than their wildtype counterparts.
Whilst most malignancies are associated with multiple independent genetic lesions, the BCR/ABL fusion protein represents a single genetic event that is sucient to induce chronic phase CML (Li et al., 1999) . Our current model of BCR/ABL signaling (Figure 8 ) highlights the importance of combined inhibition of multiple eector pathways or proximal inhibition of BCR/ABL signal transduction for the treatment of early phase CML. Pharmaceutical agents that block single eector pathways would be predicted to be far less eective than agents that simultaneously block multiple BCR/ABL pathways, such as the ABL speci®c kinase inhibitor STI-571 (Druker et al., 1996) . For many myeloproliferative disorders (MPDs) and leukemias, the initiating genetic event or primary oncogene is unknown, but the signaling pathways responsible for aberrant cell survival or proliferation are likely to be similar to those involved in CML. Therefore, a better understanding of the signaling requirements for BCR/ABL transformation will be useful in designing pathway directed therapies that may be applied to not only CML but also to a wider variety of cancers.
Materials and methods
Retroviral constructs
Dominant negative (DN) mutants of STAT5a (aa 1 ± 713) and STAT5b (aa 1 ± 718) were obtained from J Ihle, St. Jude Children's Research Hospital ; the kinase defective mutant of Akt (K179A/T308A/S473A) was obtained from J Woodgett, Ontario Cancer Institute . The constitutively active (CA) mutant of STAT5a (H299R/S711F) was a gift from T Kitamura, University of Tokyo (Onishi et al., 1998) and the myristolated (myr) form of Akt was obtained from NN Ahmed, Fox Chase Cancer Center (Ahmed et al., 1997) . Each of these cDNAs was cloned upstream of the internal ribosomal entry site (IRES) of the bicistronic retroviral vector MSCV-IRES-GFP. Dominant active (61L) and dominant negative (17N) mutants of H-Ras were cloned into either the pZIPneo retroviral vector as described previously (Sassone-Corsi et al., 1989) or MSCV-IRES-GFP. RT ± PCR (see below) was used to generate cDNAs encoding Pim-1 and Bcl-XL with the following primer sets: Pim-1 sense 5'-CGGCGGCGG-GATCGGCAGTAG-3', antisense 5'-CCCCAACACCCCA-GCAAGCGTCAC-3'; Bcl-XL sense 5'-CTGGTCGCCGGA-GATAGATTTGAA-3', antisense 5'-GGGAGGTGAGAG-GTGAGTGGAC-3'. Pim-1 was cloned into MSCV-IRES-GFP whereas Bcl-XL was cloned into the MSCVneo retroviral vector.
Retroviral transduction
High titer retroviral supernatants were generated by calciumphosphate transfection of 9 mg of the PCL-eco vector (Inder Verma, Salk Institute) and 9 mg of either the recombinant MSCV-IRES-GFP, pZIPneo, or MSCVneo constructs into the phoenix packaging cell line (G Nolan, Stanford University). Supernatants were collected 36 ± 72 h posttransfection and immediately stored at 7858C. Retroviral transductions were performed by exposing 1610 6 cells to 2 ml of retroviral supernatant in the presence of 8 mg/ml polybrene, followed by centrifugation at 15006g at 308C for 1 h 30 min and subsequent incubation at 378C for 18 ± 24 h. Transduced cells were selected for either GFP expression (green¯uorescence) by FACS or neomycin resistance by exposure to 2 mg/ml G418.
Cell culture
BaF3 was originally described as a murine pre-B lymphoid cell line that depends on IL-3 for survival and proliferation (Palacios and Steinmetz, 1985) . BaF3 cells were grown in Figure 8 A model for the signaling pathways that mediate cytokine-independent survival, proliferation and protection from DNA damage-induced apoptosis in hematopoietic cells transformed by BCR/ABL RPMI 1640 media+10% inactivated fetal bovine serum (IFS)+5% WEHI-3B conditioned medium (a source of IL-3). BaF3 cells expressing the 210 kd form of BCR/ABL have been previously described (Daley and Baltimore, 1988) and were grown in RPMI+10% FBS in the absence of WEHI-3B conditioned medium. The phoenix retroviral packaging cell line (G Nolan, Stanford University) was maintained in Dulbecco's modi®ed eagle's medium supplemented with 10% IFS.
Electromobility shift assay (EMSA)
To generate whole cell extracts, cytokine-starved cells or cells stimulated with 25 ng/ml IL-3 for 15 min were washed in cold PBS and resuspended in EMSA lysis buer (150 mM NaCl, 20 mM Tris-HCL, pH 7.4, 1 mM EDTA, 10 mM Na 3 VO 4 , 1 mM MgCl 2 , 1% NP-40, 1 mM phenylmethylsulfonyl¯uoride and 10% glycerol) at 48C. Protein extracts were immediately frozen at 7858C. Complementary oligonucleotides that contained a STAT5 consensus binding site from the b-casein promoter (5'-AGATTTCTAGGAATT-CAATCC-3') or an AP-1 consensus binding site (5'-CGCTTGATGACTCAGCCGGAA-3') were annealed and radiolabeled with [g-32 P]ATP using T4 polynucleotide kinase (New England Biolabs, Beverly, MA, USA). Approximately 25 000 c.p.m. (0.2 ng) of probe was incubated with 20 mg of whole-cell extract in 20 ml of 10 mM HEPES, pH 7.9, 50 mM KCl, 0.2 mM DTT, 10% glycerol, 0.05% Nonidet P-40, 1 mg poly-dIdC (Sigma, St. Louis, MO, USA) for 20 min at room temperature. In some cases, 5 ml (2000 mg/ml of antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was added and the reaction was left to incubate for an additional 15 min. Resulting DNA/protein complexes were resolved on a 5% nondenaturing polyacrylamide gel.
In vitro kinase assay
To measure Akt kinase activity, cells were washed in cold PBS and resuspended in Akt lysis buer (1% NP-40, 10% glycerol, 20 mM Tris-HCL, pH 7.4, 137 mM NaCl, 5 mM PMSF, 20 mM NaF, 1 mM NaPPi and 2 mM Na 3 VO 4 ) at 48C. Lysates were pre-cleared with Protein A/G plus agarose (Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 10 min at 48C followed by centrifugation at 10 000 g. One mg of protein was immunoprecipitated with an anti-Cterminal Akt antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) followed by incubation with Protein A/G plus agarose. Immunoprecipitates were washed three times in lysis buer followed by resuspension in 20 ml of kinase reaction buer (20 mM HEPES, pH 8.0, 10 mM MgCl 2 , 10 mM MnCl 2 , 10 mCi [g-32 P]ATP, 5 mM ATP and 0.25 mg/ml histone 2B). Reactions were incubated at room temperature for 20 min after which time TCA precipitated counts were determined.
RNA isolation and RT ± PCR
Total RNA was isolated from cytokine-starved cells using RNA ± STAT (Tel-test), according to manufacturer's directions. First strand synthesis was performed on 5 mg of RNA using the Superscript II RT kit (Gibco Life Technologies). Gene expression was analysed by PCR using cDNA speci®c primers and the following cycling conditions: 948C, 20 s; 588C, 30 s; and 728C, 40 s. The primer pairs used (sense/ antisense) were as follows: Bcl-XL, 5'-CTGGTCGCCGGA-GATAGATTTGAA-3'/5'-GGGAGGTGAGAGGTGAGT-GGAC-3'; Pim-1, 5'-TGGCTTCGGCTCGGTCTACTCT-3'/ 5'-GATTTCGCCGCGGCTCAGGTC-3'; c-Myc, 5'-CGCC-CGCGCCCAGTGAGGATA-3' / 5'-TGCGGCGTAGTTGT-GCTGGTGAGT-3'; Dub-1, 5'-GAAGCCCTCCCATATTT-TGACC-3'/5'-TGTTACCCGTGAAGGCTGAGAA-3'; Cis, 5'-CCTTCGGGAATCTGGGTGGTA-3'/5'-GCCGGGGCA-GGGGTAAGCAGTC; Oncostatin M, 5'-TCACGGGGAA-CACAGAATCACT-3'/5'-TATCCCCAGAGAAAGCCACA-GC-3'; c-Fos, 5'-TTCCCCAGCCGACTCCTTCTCC-3'/5'-GGGCTGCCAAAATAAACCCA-3'. Aliquots of PCR reactions were resolved by agarose gel electrophoresis. Reactions were analysed when in linear range of ampli®cation, which was determined empirically for each set of primers.
Induction of DNA damage
Cells were seeded at a density of 5610 4 cells/ml, and were irradiated with 500 cGy using a 137-cesium source . Viability of cells post cytokine withdrawal or irradiation was determined by Trypan blue exclusion.
Abbreviations EMSA, electromobility shift assay; IL-3, interleukin 3; DN, dominant negative; CA, constitutively active
